Search results
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
Motley Fool via Yahoo Finance· 10 hours agoHere are three reasons why the stock is worth buying. 1. Casgevy is about to start ramping up...
Innovative Thinking Could Make New Sickle Cell Treatments More Accessible
Scientific American· 4 days agoLast fall, to great fanfare, US regulators approved two gene therapies for sickle cell disease, and...
Seeking a sickle cell cure: 12-year-old in DC is 1st patient in US to get new gene therapy
NBC Washington· 4 days agoA 12-year-old boy who suffers debilitating pain because of sickle cell disease has become the first...
Sickle Cell Sanctuary offers new care option for thousands of Georgians
WAGA fox local articles via Yahoo News· 4 days agoThe Sickle Cell Sanctuary opening in Atlanta next month will offer holistic care in a spa-like facility for people living with sickle cell disease. And, it is all free.
What Is the Rarest Blood Type?
Verywell Health via Yahoo News· 4 days agoFortunately, because this risk is well understood, preventative medications can be used to inhibit this reaction from occurring. Variants in Rh proteins...
Former Oak Park basketball standout JD Slajchert has turned tragedy into a heartfelt mission
Los Angeles Daily News· 4 days agoAfter Bodden died in 2016 at 10 years old, pizza turned into life lessons, a novel and a fight...
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Motley Fool via Yahoo Finance· 9 hours agoEarlier this year, the company's gene editing therapy, Casgevy, obtained approval from regulators to treat transfusion-dependent beta thalassemia. Prior...
12-Year-Old Begins Newly Approved Sickle Cell Gene Therapy That Could Provide Cure
Black Enterprise· 2 days agoKendric Cromer, 12, is the first patient in the United States to undergo a newly approved gene...
JD Supra: CMS Proposes Important Enhancements to the New Technology Add-on Payment Program in the FY...
JD Supra· 24 hours agoProposals include increasing the number of manufacturers eligible for a full three years of NTAP, determining those applicants in a “hold status” with the FDA will no longer be considered inactive ...
Make-A-Wish Foundation awards Mississippi boy a trip to Disney World
WAPT Jackson· 3 days agoA wish came true for a Mississippi kid battling sickle cell disease. Ten-year-old Anthony...
